RESUMO
During January-February 2020, parts of China faced restricted mobility under COVID-19 quarantines, which have been associated with improved air quality. Because particulate pollutants scatter, diffuse, and absorb incoming solar radiation, a net negative radiative forcing, decreased air pollution can yield surface warming. As such, this study (1) documents the evolution of China's January-February 2020 air temperature and concurrent particulate changes; (2) determines the temperature response related to reduced particulates during the COVID-19 quarantine (C19Q); and (3) discusses the conceptual implications for temperature-dependent disease transmission. C19Q particulate evolution is monitored using satellite analyses, and concurrent temperature anomalies are diagnosed using surface stations and Aqua AIRS imagery. Meanwhile, two WRF-Chem simulations are forced by normal emissions and the satellite-based urban aerosol changes, respectively. Urban aerosols decreased from 27.1% of pre-C19Q aerosols to only 17.5% during C19Q. WRF-Chem resolved ~0.2 °C warming across east-central China, that represented a minor, though statistically significant contribution to C19Q temperature anomalies. The largest area of warming is concentrated south of Chengdu and Wuhan where temperatures increased between +0.2-0.3 °C. The results of this study are important for understanding the anthropogenic forcing on regional meteorology. Epidemiologically, the marginal, yet persistent, warming during C19Q may retard temperature-dependent disease transmission, possibly including SARS-CoV-2.
Assuntos
Poluentes Atmosféricos , Poluição do Ar , COVID-19 , Aerossóis/análise , Poluentes Atmosféricos/análise , Poluição do Ar/análise , China/epidemiologia , Monitoramento Ambiental , Humanos , Material Particulado/análise , Quarentena , SARS-CoV-2RESUMO
BACKGROUND: Granuloma annulare (GA) and the related annular elastolytic giant cell granuloma (AEGCG) and interstitial granulomatous dermatitis (IGD) are idiopathic histiocytic inflammatory disorders, which are frequently recalcitrant to treatment. OBJECTIVES: Evaluate the efficacy of sulphasalazine in treating GA, AEGCG and IGD. METHODS: Sixteen patients were identified with granulomatous disease who were treated with sulphasalazine between September 2015 and September 2019. Outcomes were based on patients' and providers' subjective evaluations. RESULTS: Sixteen patients were included in the study (ages 56-89, four male and twelve female). Previous treatments were attempted in fifteen patients. Clinical improvement was seen in fourteen patients (87.5%). Initial improvement was noted within a mean (SD) of 66.4 (35.1) days after starting therapy, with increasing benefits over time. Ten patients (62.5%) reported complete or near-complete clearance, three patients (18.8%) reported significant improvement, and one (6.3%) reported partial improvement. Twelve patients elected to stop or reduce therapy, resulting in relapse or worsening in five patients. CONCLUSIONS: Sulphasalazine may be considered as treatment for GA and GA-related conditions.
Assuntos
Dermatite , Granuloma Anular , Granuloma de Células Gigantes , Idoso , Idoso de 80 Anos ou mais , Dermatite/tratamento farmacológico , Feminino , Granuloma , Granuloma Anular/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Sulfassalazina/uso terapêuticoRESUMO
BACKGROUND: Peatlands are an important component of Canada's landscape, however there is little information on their national-scale net emissions of carbon dioxide [Net Ecosystem Exchange (NEE)] and methane (CH4). This study compiled results for peatland NEE and CH4 emissions from chamber and eddy covariance studies across Canada. The data were summarized by bog, poor fen and rich-intermediate fen categories for the seven major peatland containing terrestrial ecozones (Atlantic Maritime, Mixedwood Plains, Boreal Shield, Boreal Plains, Hudson Plains, Taiga Shield, Taiga Plains) that comprise > 96% of all peatlands nationally. Reports of multiple years of data from a single site were averaged and different microforms (e.g., hummock or hollow) within these peatland types were kept separate. A new peatlands map was created from forest composition and structure information that distinguishes bog from rich and poor fen. National Forest Inventory k-NN forest structure maps, bioclimatic variables (mean diurnal range and seasonality of temperatures) and ground surface slope were used to construct the new map. The Earth Observation for Sustainable Development map of wetlands was used to identify open peatlands with minor tree cover. RESULTS: The new map was combined with averages of observed NEE and CH4 emissions to estimate a growing season integrated NEE (± SE) at - 108.8 (± 41.3) Mt CO2 season-1 and CH4 emission at 4.1 (± 1.5) Mt CH4 season-1 for the seven ecozones. Converting CH4 to CO2 equivalent (CO2e; Global Warming Potential of 25 over 100 years) resulted in a total net sink of - 7.0 (± 77.6) Mt CO2e season-1 for Canada. Boreal Plains peatlands contributed most to the NEE sink due to high CO2 uptake rates and large peatland areas, while Boreal Shield peatlands contributed most to CH4 emissions due to moderate emission rates and large peatland areas. Assuming a winter CO2 emission of 0.9 g CO2 m-2 day-1 creates an annual CO2 source (24.2 Mt CO2 year-1) and assuming a winter CH4 emission of 7 mg CH4 m-2 day-1 inflates the total net source to 151.8 Mt CO2e year-1. CONCLUSIONS: This analysis improves upon previous basic, aspatial estimates and discusses the potential sources of the high uncertainty in spatially integrated fluxes, indicating a need for continued monitoring and refined maps of peatland distribution for national carbon and greenhouse gas flux estimation.
RESUMO
BACKGROUND: Fibrotic stricture is a common complication of Crohn's disease (CD) affecting approximately half of all patients. No specific anti-fibrotic therapies are available; however, several therapies are currently under evaluation. Drug development for the indication of stricturing CD is hampered by a lack of standardised definitions, diagnostic modalities, clinical trial eligibility criteria, endpoints and treatment targets in stricturing CD. AIM: To standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Chron's disease. METHODS: An interdisciplinary expert panel consisting of 15 gastroenterologists and radiologists was assembled. Using modified RAND/University of California Los Angeles appropriateness methodology, 109 candidate items derived from systematic review and expert opinion focusing on small intestinal strictures were anonymously rated as inappropriate, uncertain or appropriate. Survey results were discussed as a group before a second and third round of voting. RESULTS: Fibrotic strictures are defined by the combination of luminal narrowing, wall thickening and pre-stenotic dilation. Definitions of anastomotic (at site of prior intestinal resection with anastomosis) and naïve small bowel strictures were similar; however, there was uncertainty regarding wall thickness in anastomotic strictures. Magnetic resonance imaging is considered the optimal technique to define fibrotic strictures and assess response to therapy. Symptomatic strictures are defined by abdominal distension, cramping, dietary restrictions, nausea, vomiting, abdominal pain and post-prandial abdominal pain. Need for intervention (endoscopic balloon dilation or surgery) within 24-48 weeks is considered the appropriate endpoint in pharmacological trials. CONCLUSIONS: Consensus criteria for diagnosis and response to therapy in stricturing Crohn's disease should inform both clinical practice and trial design.
Assuntos
Consenso , Doença de Crohn/terapia , Prova Pericial , Obstrução Intestinal/diagnóstico , Obstrução Intestinal/terapia , Guias de Prática Clínica como Assunto/normas , Cateterismo/métodos , Cateterismo/normas , Ensaios Clínicos como Assunto/normas , Ensaios Clínicos como Assunto/estatística & dados numéricos , Colo/patologia , Colo/cirurgia , Constrição Patológica/diagnóstico , Constrição Patológica/etiologia , Constrição Patológica/terapia , Doença de Crohn/complicações , Doença de Crohn/diagnóstico , Dilatação/métodos , Dilatação/normas , Endoscopia , Fibrose/diagnóstico , Fibrose/etiologia , Fibrose/terapia , Humanos , Obstrução Intestinal/classificação , Obstrução Intestinal/etiologia , Intestino Delgado/patologia , Intestino Delgado/cirurgia , Padrões de ReferênciaRESUMO
Altered tissue structure is a feature of many disease states and is usually measured by microscopic methods, limiting analysis to small areas. Means to rapidly and quantitatively measure the structure and organisation of large tissue areas would represent a major advance not just for research but also in the clinic. Here, changes in tissue organisation that result from heterozygosity in Apc, a precancerous situation, are comprehensively measured using microultrasound and three-dimensional high-resolution microscopy. Despite its normal appearance in conventionally examined cross-sections, both approaches revealed a significant increase in the variability of tissue organisation in Apc heterozygous tissue. These changes preceded the formation of aberrant crypt foci or adenoma. Measuring these premalignant changes using microultrasound provides a potential means to detect microscopically abnormal regions in large tissue samples, independent of visual examination or biopsies. Not only does this provide a powerful tool for studying tissue structure in experimental settings, the ability to detect and monitor tissue changes by microultrasound could be developed into a powerful adjunct to screening endoscopy in the clinic.
Assuntos
Focos de Criptas Aberrantes/diagnóstico por imagem , Proteína da Polipose Adenomatosa do Colo/genética , Imageamento Tridimensional/métodos , Intestinos/diagnóstico por imagem , Intestinos/patologia , Focos de Criptas Aberrantes/patologia , Animais , Sobrevivência Celular , Feminino , Humanos , Masculino , Camundongos , Microscopia , Microtecnologia , Mutação , UltrassonografiaRESUMO
CONTEXT: During the pubertal transition, LH secretion initially increases only during sleep; however, its relationship to sleep stage is unknown. OBJECTIVES: Our objective was to determine whether the initiation of LH pulses is related to a specific sleep stage in pubertal children. DESIGN AND SETTING: Frequent blood sampling and polysomnographic studies were performed in a Clinical Research Center. SUBJECTS: Fourteen studies were performed in nine healthy pubertal children, ages 9.9-15.6 yr. INTERVENTIONS: Subjects underwent one to two overnight studies with polysomnography and blood sampling for LH at 10-min intervals. RESULTS: Alignment of polysomnographic records and LH pulses demonstrated that LH pulses (n = 58) occurred most frequently during slow-wave sleep (SWS) (1.1 pulse/h, n = 30) compared with all other sleep stages or periods of wake after sleep onset (P < 0.001). There was also a significant increase in the amount of SWS in the 15 min preceding and the 5 min following each pulse compared with the amount of SWS seen across the study night (P < 0.01). CONCLUSIONS: During puberty, the majority of LH pulses that occur after sleep onset are preceded by SWS, suggesting that SWS is intimately involved in the complex control of pubertal onset. These studies raise concerns about the potential hormonal repercussions of the increasing prevalence of sleep disturbances in adolescents.
Assuntos
Hormônio Luteinizante/metabolismo , Puberdade/fisiologia , Fases do Sono/fisiologia , Adolescente , Criança , Feminino , Humanos , Hormônio Luteinizante/sangue , Masculino , Periodicidade , Polissonografia , Puberdade/sangueRESUMO
The objective of this study was to evaluate the effect of 1h, bilateral, warm ischemia-reperfusion kidney injury as a model of acute kidney injury in the cat. Four adult healthy cats underwent 60 min of bilateral, in vivo renal warm ischemia; three cats were sham operated controls. Kidney function was evaluated with creatinine and BUN concentration, urine protein: creatinine, and glomerular filtration rate. Post-reperfusion endothelin and renin was measured by ELISA and RT-qPCR. Blood pressure (BP), platelet count, and platelet aggregation were monitored. Renal biopsy specimens were evaluated histopathologically. There was significant reduction in renal function characterized by severe azotemia and proximal tubular brush border loss. Changes in renin or endothelin gene expression or serum concentration were not detected. No changes were detected in BP. Platelet count and hematocrit decreased markedly after ischemia and reperfusion. Sixty minutes bilateral renal ischemia is an effective model for acute renal injury.
Assuntos
Injúria Renal Aguda/veterinária , Doenças do Gato/patologia , Traumatismo por Reperfusão/veterinária , Injúria Renal Aguda/patologia , Animais , Azotemia/veterinária , Pressão Sanguínea , Gatos , Feminino , Rim/patologia , Rim/fisiologia , Masculino , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase em Tempo Real/veterinária , Renina/sangueRESUMO
Using a differential display RT-PCR strategy to identify novel growth-factor-induced transcripts, we cloned and characterized the human homolog of yeast NOP5/NOP58, whose gene product has been implicated in the execution of early pre-rRNA processing steps. Human NOP5 cDNA was isolated from an M426 fibroblast cDNA library. Determination of the cDNA nucleotide sequence revealed an open reading frame of 1587 nucleotides encoding a predicted gene product of 529 amino acids and mass of 59554Da. The yeast and human NOP5 gene products were found to share 63% homology and 46% identity. NOP5 mRNA was induced within 2h of platelet-derived growth factor (PDGF) treatment of human M426 fibroblasts. Pretreatment with cycloheximide enhanced, while actinomycin blocked induction of the NOP5 transcript. In vitro translational analysis of the cDNA revealed a 60kDa species, consistent with the predicted molecular weight of the gene product. Ubiquitous, but differential NOP5 mRNA expression was revealed after Northern blot analysis of total RNA from several human tissues. Moreover, NOP5 mRNA expression was also demonstrated in cell lines of fibroblast, epithelial, and myeloid origin. A highly charged carboxy terminal domain and consensus phosphorylation sites were identified. The presence of potential regulatory elements, together with growth factor induction and widespread expression is consistent with the hypothesis that the NOP5 gene product may play a role in fundamental cellular growth processes.
Assuntos
DNA Complementar/isolamento & purificação , Proteínas Nucleares , Fator de Crescimento Derivado de Plaquetas/farmacologia , Ribonucleoproteínas Nucleolares Pequenas/genética , Sequência de Aminoácidos , Sequência de Bases , Northern Blotting , Linhagem Celular , DNA Complementar/química , DNA Complementar/genética , Feminino , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Células K562 , Dados de Sequência Molecular , Biossíntese de Proteínas , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Proteínas de Saccharomyces cerevisiae , Análise de Sequência de DNA , Distribuição Tecidual , Células Tumorais CultivadasRESUMO
A sensitive method for staining proteins after transfer from polyacrylamide gels to nitrocellulose paper is described. Transferred proteins are first derivatized by reaction of the nitrocellulose replica with sulfosuccinimidobiotin and are then reacted sequentially with streptavidin, rabbit anti-streptavidin, and horseradish peroxidase-conjugated goat anti-rabbit IgG antibody. Incubation with the enzyme substrate alpha-chloronaphthol, produces dark protein bands against a white background. The binding of streptavidin to the proteins is dependent on biotin derivatization as demonstrated by competition with biotinylated bovine serum albumin or 10 nM biotin. The procedure detects less than 5 ng of transferred protein in a single band and is thus 5-10 times more sensitive than horseradish peroxidase-conjugated avidin alone. For bovine serum albumin, the method is comparable in sensitivity to silver staining of protein in polyacrylamide gels.
Assuntos
Antígenos de Superfície/análise , Avidina , Biotina , Técnicas Imunoenzimáticas/normas , Proteínas de Membrana/análise , Coloração e Rotulagem/métodos , Estreptavidina , Animais , Anticorpos Monoclonais/imunologia , Antígenos de Superfície/imunologia , Colódio , Eletroforese em Gel de Poliacrilamida , Proteínas de Membrana/imunologia , CoelhosRESUMO
Identification of the transcriptionally activated targets of receptor tyrosine kinases is critical to understanding biologic programs directing both normal and neoplastic growth. To elucidate these molecular processes, we identified genes induced by a potent mesenchymal mitogen, platelet-derived growth factor (PDGF). Using differential display reverse transcription-polymerase chain reaction technology, we isolated a novel growth factor-induced cDNA, San5. San5 transcript induction occurred within 60 min in NIH 3T3 fibroblasts and proceeded in the presence of cycloheximide. Maximal induction of the San5 transcript occurred between 8 and 16 h, concurrent with passage of fibroblasts through G(1). San5 message was potently induced by PDGF AA and BB and acidic and basic fibroblast growth factors, all strong activators of fibroblast proliferation, but not by epidermal growth factor and interleukin-4. In a murine hematopoietic progenitor cell line, San5 transcript induction strictly correlated with [(3)H]thymidine uptake. Isolation and sequencing of the murine San5 cDNA revealed amino acid sequence homology to yeast Nop5p, a nucleolar protein required for pre-rRNA processing and ribosome assembly. Strikingly, SAN5 was able to rescue a nop5 null mutant, implicating SAN5 in the process of ribosome biogenesis. Consistent with this result, SAN5 was localized to the nucleolus in both yeast and mouse. Thus, San5 may provide a link between growth factor receptor activation and the cellular translational machinery.
Assuntos
DNA Complementar/genética , Regulação Fúngica da Expressão Gênica , Fator de Crescimento Derivado de Plaquetas/genética , Ribossomos/fisiologia , Saccharomyces cerevisiae/fisiologia , Células 3T3 , Sequência de Aminoácidos , Animais , DNA Complementar/isolamento & purificação , Camundongos , Dados de Sequência Molecular , Fator de Crescimento Derivado de Plaquetas/biossíntese , Alinhamento de SequênciaRESUMO
Aberrant communication among growth factors and cytokines that regulate tissue homeostasis often results in malignancy. Among the many cell types that participate in this process, stromal fibroblasts communicate in a paracrine and juxtracrine manner with cells of epithelial, endothelial, and hematopoietic origin. For fibroblasts, platelet-derived growth factor (PDGF) is a major proliferative and differentiation agent. Interleukin-4 (IL-4), however, possesses only modulating functions in this cell type. Here, we investigated the consequences of deleting Stat6 on PDGF and IL-4 signaling, proliferation, and transcriptional activation by establishing and characterizing early passage fibroblasts from wild-type and Stat6 null mice. Both wild-type and Stat6-/- fibroblasts showed nearly identical PDGFR and IL-4R activation, gross substrate tyrosine phosphorylation, PI 3-kinase activation, as well as Stat1, 3 and 5 DNA binding activities. Unexpectedly, IL-4's enhancement of PDGF-induced [3H]thymidine incorporation was greatly diminished in Stat6-/-, but not wild-type fibroblasts. PDGF-induced [3H]thymidine uptake was largely unaffected. Strikingly, IL-4, but not PDGF induction of the proinflammatory gene products, IL-6 and MCP-1 was markedly reduced in Stat6-/- fibroblasts. Thus, Stat6 is an important and specific mediator of IL-4-enhanced PDGF-induced proliferation as well as IL-4's transcriptional activation of IL-6 and MCP-1.
Assuntos
Fibroblastos/patologia , Fibroblastos/fisiologia , Interleucina-4/farmacologia , Fator de Crescimento Derivado de Plaquetas/farmacologia , Transdução de Sinais/genética , Transativadores/genética , Ativação Transcricional/genética , Animais , Divisão Celular/efeitos dos fármacos , Divisão Celular/genética , Linhagem Celular Transformada , Deleção de Genes , Camundongos , Fator de Transcrição STAT6 , Transdução de Sinais/efeitos dos fármacos , Ativação Transcricional/efeitos dos fármacosRESUMO
The developing mammalian cochlea is especially sensitive to chemical toxins. In rats, the period of increased sensitivity falls roughly between postnatal days (P) 8 and 28. One unexplored hypothesis for this 'sensitive period' is that young cochleas may have immature complements of detoxification enzymes. Glutathione-S-transferases (GSTs) are a family of detoxification enzymes which catalyze the conjugation of many xenobiotics to glutathione. Using high performance liquid chromatography (HPLC), we measured the concentrations of soluble GST isoforms in cochleas of developing Fischer 344 rats. At P1, the concentration of isoform rGSTP1 was 9 pmol/mg protein. That of the remaining isoforms studied was low, <2 pmol/mg protein, and, except for rGSTA3, remained so throughout the period of study. At P2, immunolabelling visualized rGSTP1 in the stria vascularis, Reissner's membrane, spiral limbus and organ of Corti. From P1 to P28, rGSTP1 increased to 15 pmol/mg protein and was detected additionally in satellite cells of the spiral ganglion and in the spiral ligament. From P7 to P28, rGSTA3 increased 8-fold (3-24 pmol/mg protein), became the predominant isoform in the adult organ and localized to pillar cells, the limbus and the spiral ligament. In the vestibule, rGSTP1 predominated, although rGSTA3 increased slightly over time. These observations suggest that biochemical immaturity in detoxification enzymes in the cochlea may contribute to the increased sensitivity to ototoxins during development and that differences in detoxification enzymes between cells in the cochlea and between inner ear organs may underlie differences in susceptibility to ototoxins.
Assuntos
Cóclea/enzimologia , Cóclea/crescimento & desenvolvimento , Glutationa Transferase/metabolismo , Animais , Cóclea/efeitos dos fármacos , Resistência a Medicamentos , Feminino , Imuno-Histoquímica , Inativação Metabólica , Isoenzimas/metabolismo , Masculino , Ratos , Ratos Endogâmicos F344 , Xenobióticos/metabolismo , Xenobióticos/toxicidadeRESUMO
The effect of acute exposure to lead acetate on the expression of glutathione S-transferase (GST) subunits and the levels of reduced and oxidized glutathione (GSH) and malondialdehyde (MDA) in rat kidney and liver was determined. The purpose of this study was to determine if GSH depletion and/or oxidative stress were responsible for changes in the expression of some or all GSTs that followed lead exposure. In kidney, all GST subunits increased following injection of lead. The level of kidney GSH was not changed at either 0.5 or 1 h after lead exposure, but increased 3, 6, 12 and 24 h after a single injection of lead. MDA levels (a marker of lipid peroxidation) did not change in kidney following lead injection. Immunohistochemical markers of oxidative stress and nitric oxide production were also unchanged by lead administration. Therefore. we conclude that the increases in GST levels in kidney following lead exposure were not dependent on oxidative stress. In liver, lead injection caused GSH depletion (61% of control 12 h after lead treatment) and increased MDA production (2.5-fold increase 6 h after lead exposure), while GSTA1, GSTA2, GSTM1 and GSTM2 did not increase. Analysis of the effects of lead on GST mRNA and GST cellular localization were performed by Northern blot and immunohistochemical techniques. Immunoperoxidase light microscopy and immunogold electron microscopy revealed that the increase in kidney GSTM1 and GSTP1 occurred in nuclei, cytoplasm and microvilli of proximal tubules. Northern blot analysis of GSTA2 and GSTP1 mRNAs showed that their increase following lead exposure was inhibited by actinomycin D, suggesting transcriptional induction. This study demonstrates that acute lead exposure causes dramatic changes in the subcellular distribution and expression of rat kidney GSTs, and that these changes are not a result of oxidative stress.
Assuntos
Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Glutationa Transferase/biossíntese , Rim/metabolismo , Chumbo/toxicidade , Fígado/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Animais , Northern Blotting , Glutationa/metabolismo , Imuno-Histoquímica , Rim/efeitos dos fármacos , Rim/enzimologia , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/enzimologia , Malondialdeído/metabolismo , Estresse Oxidativo/fisiologia , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Frações Subcelulares/efeitos dos fármacos , Frações Subcelulares/metabolismoRESUMO
Glutathione S-transferases (GST) are a family of detoxification isoenzymes that catalyze the conjugation of xenobiotics and their metabolites with reduced glutathione. Lead exposure in rats is known to induce GST isoenzymes in the liver and kidney. These changes in expression have potential use as biomarkers of lead exposure. Because two-dimensional electrophoresis (2-DE) enables one to analyze both protein abundance changes and chemical changes in protein structure, 2-DE was used to determine the effect of in vivo lead exposure on GST isoform expression in rat kidney cytosols. Male Sprague-Dawley rats were exposed to inorganic lead, and proteins were separated by conventional ISO-DALT and NEPHGE-DALT techniques and blotted for immunological identification. Lead exposure caused detectable inductions in both GSTP1 and GSTM1 and quantifiable charge modification in GSTP1. These preliminary data confirm the utility of 2-D electrophoretic GST analysis as indicative of lead exposure and toxicity and support its use for further elaboration of lead's effects on renal protein expression.
Assuntos
Eletroforese em Gel Bidimensional , Glutationa Transferase/análise , Chumbo/farmacologia , Animais , Eletroforese em Gel Bidimensional/métodos , Masculino , Ratos , Ratos Sprague-DawleyRESUMO
Different steroid hormone receptors can activate transcription from the same hormone response element (HRE) in vitro, but in vivo the effects of each hormone on gene activity are distinct. To determine sequences mediating androgen-specific response in a physiological setting, we placed the androgen-responsive mouse sex-limited protein gene (Slp) enhancer before a tkCAT reporter in transgenic mice. The enhancer contains a consensus HRE plus accessory factor binding sites that act in concert to direct transcription in response to androgen. A 160 bp fragment, C'delta2, is responsive to several steroids in transfection; in transgenic mice, this enhancer was active in several tissues of male and female mice, in four of six transgenic lines. In striking contrast, C'delta9, a 120 bp sub-fragment of C'delta2 that responds only to androgen in transfection, showed activity in testes, prostate and kidney, where it was strongly androgen-inducible in females. However, expression was obtained in only one transgenic line. Multimerization of the C'delta9 enhancer conferred expression in prostate, but again in only one line. The greater penetrance of C'delta2 expression was not driven by glucocorticoids, as adrenalectomy had little effect, but may be dependent on the NF-kappaB-like element absent from the C'delta9 fragment. That two transgenic lines showed expression in androgen target sites driven by enhancers that are androgen-specific in vitro suggested that activation of this enhancer, when it could occur, was in response to androgen. The dramatically different behavior of the two related enhancer sequences underscores the importance of chromosomal context to the activity and specificity of regulatory elements.
Assuntos
Androgênios/fisiologia , Proteínas Sanguíneas/genética , Elementos Facilitadores Genéticos/genética , Ativação Transcricional/genética , Glândulas Suprarrenais/fisiologia , Adrenalectomia , Animais , Complemento C4 , Dexametasona/farmacologia , Feminino , Glucocorticoides/farmacologia , Masculino , Camundongos , Camundongos Transgênicos , Especificidade de Órgãos , Proteínas Recombinantes de Fusão , Testosterona/farmacologia , Ativação Transcricional/efeitos dos fármacosRESUMO
The mouse sex-limited protein (Slp) gene is expressed in liver and kidney of adult males and is testosterone-inducible in females, indicative of androgen dependence. Analysis of mRNA levels and chromatin configuration reveals that this androgen regulation is achieved by distinct means in the two tissues. In the liver, Slp expression requires pituitary function, and specifically, as shown by others, a pulsatile pattern of GH secretion that is itself determined by androgen. After hypophysectomy, Slp synthesis cannot be reestablished in liver by testosterone, although mRNA decline can be slowed. In contrast, in the kidney Slp mRNA is directly induced by androgen in hypophysectomized mice. In vivo footprinting was used to examine the role of the Slp enhancer, which directs androgen-specific transcription in transfection and contains a factor-binding site, FPIV, whose protection in vivo has been correlated with Slp expression. In kidney, FPIV was protected in intact males and hypophysectomized mice supplemented with testosterone, but not in females or untreated hypophysectomized mice, corroborating FPIV's association with androgen-driven transcription. Surprisingly, protection of FPIV also occurred in liver of hypophysectomized males treated with testosterone, despite the lack of Slp expression. Thus androgen directly affects the Slp enhancer in kidney, where steroid is sufficient for gene activation, as well as in liver, where chromatin remodeling occurs in response to androgen, although GH is clearly required for expression. This may indicate that both GH and androgen signal transduction pathways target the Slp enhancer to elicit precise gene regulation.
Assuntos
Proteínas Sanguíneas/genética , Regulação da Expressão Gênica , Testosterona/fisiologia , Animais , Sítios de Ligação , Proteínas Sanguíneas/metabolismo , Cromatina/efeitos dos fármacos , Cromatina/metabolismo , Complemento C4 , DNA/metabolismo , Pegada de DNA , Feminino , Hormônio do Crescimento/deficiência , Hormônio do Crescimento/genética , Hormônio do Crescimento/fisiologia , Hipofisectomia , Hibridização In Situ , Rim/metabolismo , Fígado/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , RNA Mensageiro/metabolismo , Ribonucleases/metabolismo , Testosterona/genética , Ativação TranscricionalRESUMO
The effects of triethyl lead chloride (TEL) on the expression of two detoxication enzyme families, glutathione S-transferases (GSTs) and NAD(P)H:quinone oxidoreductase (QR) were determined in rat liver and kidney. Fischer 344 rats were given one intraperitoneal (i.p.) injection of TEL. GST activity, GST isoenzyme levels, mRNA levels of alpha class GST isoenzymes Ya1, Ya2, and Yc1 and activity of QR were determined. Treatment of rats with TEL caused a significant increase in GST activity in kidney. In kidney, the levels of all GST subunits were significantly elevated; the largest increase was a 3.2-fold increase in GST Yb1. The levels of GST Ya1, Ya2, and Yc1 mRNA also increased after injection of TEL. In liver, TEL injection resulted in decreased GST activity and lower levels of hepatic GSTs Yb2, Yb3, Ya1, and Ya2. The largest decrease was a 40% reduction of GST Ya1. In contrast, the level of liver GST Yc1 increased from day 4 through day 14 after injection of 10 mg/kg TEL and Yp was increased 1.4-fold 4 days after injection of 12 mg/kg TEL. The levels of liver mRNAs coding for alpha class GSTs Ya1, Ya2, and Yc1 were reduced 12 h after injection of TEL. The mRNA levels of GST Ya1 and Ya2 returned to basal level while Yc1 message increased to a level higher than controls 24 h after TEL injection. The increase in Yc1 protein between days 4 and 14 is consistent with the increase in the corresponding mRNA. The activity of QR was elevated 1.5-fold in kidney and 2.7-fold in liver 14 days after the injection of TEL. This report demonstrates that administration of organic lead significantly affects GST expression and QR activity in a tissue-specific and isoenzyme-specific manner. These results indicate that GST expression and QR activity are not co-regulated.
Assuntos
Glutationa Transferase/biossíntese , Isoenzimas/biossíntese , Rim/efeitos dos fármacos , Rim/enzimologia , Fígado/efeitos dos fármacos , Fígado/enzimologia , NAD(P)H Desidrogenase (Quinona)/biossíntese , Compostos Organometálicos/toxicidade , Animais , Glutationa Transferase/efeitos dos fármacos , Injeções Intraperitoneais , Isoenzimas/efeitos dos fármacos , Rim/metabolismo , Chumbo/toxicidade , Fígado/metabolismo , NAD(P)H Desidrogenase (Quinona)/efeitos dos fármacos , Compostos Organometálicos/administração & dosagem , Ratos , Ratos Endogâmicos F344RESUMO
Hospitals engaged in quality improvement must measure and assess customer perceptions of hospital services. Hospital customers are either "external"--patients, their families, and payers--or "internal"--physicians and hospital employees. This article describes two measurement systems designed to gather information from internal customers about the quality of hospital services. One system targets physicians, the other hospital employees. This article describes how these systems were developed and pilot-tested, and how the results were analyzed. Analysis of results showed the systems to be reliable, valid, and representative. The article also addresses limitations of the research (focus on general acute-care hospitals), interesting findings and implications (the correlation between physicians' and employees' ratings of hospital quality), and uses of these measures in corporate-level and hospital-level quality improvement (measuring trends and identifying specific opportunities for improvement).
Assuntos
Atitude do Pessoal de Saúde , Administração Hospitalar/normas , Corpo Clínico Hospitalar , Recursos Humanos em Hospital , Qualidade da Assistência à Saúde/estatística & dados numéricos , Comportamento do Consumidor/estatística & dados numéricos , Estudos de Avaliação como Assunto , Pesquisa sobre Serviços de Saúde/métodos , Satisfação no Emprego , Julgamento , Reprodutibilidade dos Testes , Inquéritos e Questionários , Estados UnidosRESUMO
A reversed-phase ion-pairing high-performance liquid chromatographic procedure with refractive index or UV 214 nm detection was developed for the separation of clindamycin, clindamycin B, and 7-epiclindamycin. The chromatographic retention behavior of these compounds on an octadecylsilane column was investigated as a function of pairing-ion, mobile phase composition, and pH. The method was applied to the determination of clindamycin in bulk drug and in a number of pharmaceutical formulations. The relative standard deviations for all assays was in the 0.5-2% range.